Hemoptysis classification

Jump to navigation Jump to search

Hemoptysis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemoptysis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemoptysis classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemoptysis classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemoptysis classification

CDC on Hemoptysis classification

Hemoptysis classification in the news

Blogs on Hemoptysis classification

Directions to Hospitals Treating Hemoptysis

Risk calculators and risk factors for Hemoptysis classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]

Overview

Classification

  • Hemoptysis may be classified into several subtypes based on:
    • Duration of symptoms
    • Severity
    • Origin of bleeding
  • Based on the duration of symptoms, hemoptysis may be classified as either acute or chronic.
  • Hemoptysis may be classified according to severity into 3 groups:[1][2][3][4][5][6]
Category Amount Percentage
Mild bleeding <30 ml blood in 24 hours
Moderate bleeding 30-300 ml blood in 24 hours
Massive bleeding 300-600 ml blood in 24 hours 5-15% of patients
  • Based on the origin of bleeding, hemoptysis may be classified into two groups:[7]
    • Pulmonary bleeding (in 90% of patients)
    • Extra-pulmonary bleeding

References

  1. Johnson JL (2002). "Manifestations of hemoptysis. How to manage minor, moderate, and massive bleeding". Postgrad Med. 112 (4): 101–6, 108–9, 113. PMID 12400152.
  2. Mal H, Thabut G, Plantier L (2003). "[Hemoptysis]". Rev Prat (in French). 53 (9): 975–9. PMID 12816036.
  3. Andersen PE (2006). "Imaging and interventional radiological treatment of hemoptysis". Acta Radiol. 47 (8): 780–92. doi:10.1080/02841850600827577. PMID 17018424.
  4. Sakr L, Dutau H (2010). "Massive hemoptysis: an update on the role of bronchoscopy in diagnosis and management". Respiration. 80 (1): 38–58. doi:10.1159/000274492. PMID 20090288.
  5. Lee MK, Kim SH, Yong SJ, Shin KC, Kim HS, Yu TS, Choi EH, Lee WY (2015). "Moderate hemoptysis: recurrent hemoptysis and mortality according to bronchial artery embolization". Clin Respir J. 9 (1): 53–64. doi:10.1111/crj.12104. PMID 24406077.
  6. Noë, G.D.; Jaffé, S.M.; Molan, M.P. (2011). "CT and CT angiography in massive haemoptysis with emphasis on pre-embolization assessment". Clinical Radiology. 66 (9): 869–875. doi:10.1016/j.crad.2011.03.001. ISSN 0009-9260.
  7. Yoon W, Kim JK, Kim YH, Chung TW, Kang HK (2002). "Bronchial and nonbronchial systemic artery embolization for life-threatening hemoptysis: a comprehensive review". Radiographics. 22 (6): 1395–409. doi:10.1148/rg.226015180. PMID 12432111.